CA2514687A1 - Composition de pointe a base de vitamine c possedant des capacites ameliorees de biotransformation et utilisation de proteines et de l-carnitine comme additifs nutritionnels ou comme substances de meme nature - Google Patents

Composition de pointe a base de vitamine c possedant des capacites ameliorees de biotransformation et utilisation de proteines et de l-carnitine comme additifs nutritionnels ou comme substances de meme nature Download PDF

Info

Publication number
CA2514687A1
CA2514687A1 CA002514687A CA2514687A CA2514687A1 CA 2514687 A1 CA2514687 A1 CA 2514687A1 CA 002514687 A CA002514687 A CA 002514687A CA 2514687 A CA2514687 A CA 2514687A CA 2514687 A1 CA2514687 A1 CA 2514687A1
Authority
CA
Canada
Prior art keywords
carnitine
vitamin
milligrams
mixture
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002514687A
Other languages
English (en)
Inventor
William Feinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2514687A1 publication Critical patent/CA2514687A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/28—Substances of animal origin, e.g. gelatin or collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

L'invention concerne un complément nutritionnel et une méthode de traitement faisant appel à ce dernier, ce complément comprenant de la vitamine C en quantité généralement comprise entre 250 milligrammes et 5000 milligrammes, en mélange avec de la L-carnitine en quantité généralement comprise entre 100 milligrammes et 5000 milligrammes, et/ou une ou plusieurs protéines qui renferment des acides aminés essentiels et dont la quantité est généralement comprise entre 1 gramme et 150 grammes.
CA002514687A 2004-06-09 2005-06-09 Composition de pointe a base de vitamine c possedant des capacites ameliorees de biotransformation et utilisation de proteines et de l-carnitine comme additifs nutritionnels ou comme substances de meme nature Abandoned CA2514687A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57876504P 2004-06-09 2004-06-09
US60/578,765 2004-06-09
PCT/US2005/020421 WO2005123108A2 (fr) 2004-06-09 2005-06-09 Composition a base de vitamine c elaboree presentant une biotransformation amelioree et utilisation de proteines et de l-carnitine pour complementation nutritionnelle ou analogue

Publications (1)

Publication Number Publication Date
CA2514687A1 true CA2514687A1 (fr) 2005-12-09

Family

ID=35478562

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002514687A Abandoned CA2514687A1 (fr) 2004-06-09 2005-06-09 Composition de pointe a base de vitamine c possedant des capacites ameliorees de biotransformation et utilisation de proteines et de l-carnitine comme additifs nutritionnels ou comme substances de meme nature

Country Status (2)

Country Link
CA (1) CA2514687A1 (fr)
WO (1) WO2005123108A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5943433B2 (ja) 2011-01-20 2016-07-05 ワンデイ − バイオテク アンド ファーマ リミテッド 抗酸化、抗炎症、抗放射線、金属キレート化合物およびその使用
JP2014532032A (ja) * 2011-04-05 2014-12-04 ロンザ・リミテッド 疲労を減少させるためまたは予防するためおよび認知機能を改善するためのｌ−カルニチン、その塩および誘導体の使用
EP2508179A1 (fr) * 2011-04-05 2012-10-10 Lonza Ltd. Utilisation de carnitine L, sels et dérivés associés pour réduire ou empêcher la fatigue et améliorer la fonction cognitive
WO2014016831A1 (fr) 2012-07-23 2014-01-30 Oneday - Biotech And Pharma Ltd. Compositions élevant le taux de glutathion et leurs utilisations
WO2014016837A1 (fr) 2012-07-25 2014-01-30 Oneday - Biotech And Pharma Ltd. Compositions et méthodes permettant d'augmenter le niveau de carnitine dans les tissus musculaires
WO2014114939A1 (fr) 2013-01-23 2014-07-31 Bottled Science Limited Composition de boisson améliorant la peau
CN103404572B (zh) * 2013-08-22 2015-04-22 北京康比特体育科技股份有限公司 一种能量补充及缓解疲劳的烘焙棒及其制备方法
SE542106C2 (en) 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
JP2018064492A (ja) * 2016-10-18 2018-04-26 株式会社明治 たんぱく質効率向上用の組成物
US10653720B2 (en) 2017-11-03 2020-05-19 Lysulin, Inc. Prevention of protein glycation using lysine/zinc supplements
US10466256B2 (en) * 2017-11-03 2019-11-05 Lysulin, Inc. Inhibiting chronic blood and nephrological disorders using lysine-based supplements
US11255838B2 (en) 2017-11-03 2022-02-22 Lysulin, Inc. Levels, functions, and resistances related to chronic conditions by using lysine-based supplements
US10610544B2 (en) 2017-11-03 2020-04-07 Lysulin, Inc. Insulin resistance and beta cell function using lysine-based supplements
CN111990574A (zh) * 2020-09-18 2020-11-27 内蒙古精晶生物科技有限公司 一种左旋肉碱营养泡腾片

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics

Also Published As

Publication number Publication date
WO2005123108A2 (fr) 2005-12-29
WO2005123108A3 (fr) 2006-05-04

Similar Documents

Publication Publication Date Title
CA2514687A1 (fr) Composition de pointe a base de vitamine c possedant des capacites ameliorees de biotransformation et utilisation de proteines et de l-carnitine comme additifs nutritionnels ou comme substances de meme nature
Jäger et al. International society of sports nutrition position stand: protein and exercise
EP0482715B1 (fr) Composition nutritionnelle
KR101075816B1 (ko) 종합 경장 영양 조성물
CA2261708A1 (fr) Composition a base de pyruvate et de proteine et procede augmentant la teneur en proteines de l'organisme d'un mammifere
ES2274246T3 (es) Utilizacion de pululano como un carbohidrato digerido lentamente.
US20040156882A1 (en) Method and composition for feeding mammals
CN108391811A (zh) 一种肿瘤全营养配方食品及其应用
CN101569410A (zh) 肿瘤患者用的特膳营养食品
Silk Towards the optimization of enteral nutrition
CN1718117A (zh) 黑木耳燕麦螺旋藻即冲饮品及其制备方法
CA2746902C (fr) Formulation multivitamines-mineraux pour lutter contre les effets du stress environnemental, renforcer l'immunite et l'energie tout en traitant des deficiences en mineraux et en v itamines sans les effets secondaires d'un complement alimentaire en mega-dose
CN102273581A (zh) 一种高甜度复配甜味剂
JP2017057147A (ja) ニンニク等、低塩分濃度の味噌、及びビタミンｂ１を含有する組成物
EP1789033B1 (fr) Glycine comme supplement dietetique pour le traitement des problemes de sante resultant de troubles metaboliques sous-jacents
US20060210606A1 (en) Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood
US7025996B1 (en) Dietary supplement for medical patients
CN108851037A (zh) 一种肾病综合征全营养食品的制备方法及其用途
CN106036387A (zh) 超级藜麦儿童生长营养包
JP3871262B2 (ja) 液状栄養組成物
CN110226756A (zh) 预防和缓解2型糖尿病患者肌少症的蛋白组件及制备方法
RU2335927C2 (ru) Обогащенные лейцином питательные композиции
CN108991358A (zh) 一种辅助降血脂、降血糖、缓解痛风保健食品及生产方法
TWM579033U (zh) Protein peptide structure
KR20110131140A (ko) 오미자 효소의 호르몬 치유와 프로테인 식이요법

Legal Events

Date Code Title Description
FZDE Dead